Skip to main content

The Cancer Clinical Trial Bootcamp is a 16-week program that guides clinical faculty and fellows in designing and writing investigator-initiated cancer clinical trial protocols. At the program’s outset, each participant presents at least two cancer-related investigator-initiated clinical trial ideas for development.

Participants meet every other Wednesday for eight 2-hour sessions led by CFCCC investigators. Each session includes a 45-minute didactic lecture followed by 1-hour of “at elbow” mentorship focused on the participant’s protocol development. 

Following each session, participants apply learned concepts to systematically write protocol components with the goal of submitting a written protocol for at least one of their cancer clinical trial ideas by the program’s conclusion.

Timeline: 

  • December 4, 2024: Call for applications released
  • January 16, 2024: Application deadline
  • February 1, 2024: Participants selected and notified
  • February 28, 2024 – June 5, 2024: Eight in-person sessions, every other Wednesday 6:00PM – 8:00PM
  • June 24, 2024: Master protocol submission deadline

Eligibility: 

  • Must be a clinical fellow/faculty member who desires a career with a substantial cancer clinical research component.
  • Must be able to attend all in-person session dates. 
  • Must commit to writing and submitting a completed master protocol by the program's conclusion.

To apply, visit the below link and submit your application by January 16, 2024. 

Session

Date

Topic

Speakers

1

Wednesday, February 28, 2024

Overview of Course; Ethical & Diversity Considerations; Generating a Hypothesis (Part 1)

Edward Nelson, MD; Jennifer Valerin, MD, PhD; Sora Tanjasiri, DrPH, MPH

2

Wednesday, March 13, 2024

Framing a Hypothesis (Part 2) & Determination of Study Endpoints

Jason Zell, DO; Joel Milam, PhD

3

Wednesday, March 27, 2024

Pre-trial Design Considerations

Warren Chow, MD; Wen-Pin Chen, MS

4

Wednesday, April 10, 2024

General Trial Design Considerations & Phase I Designs

Arash Rezazadeh, MD; Michael Hoyt, PhD

5

Wednesday, April 24, 2024

Phase II Study Designs, Evaluations & Study Calendars

Susan O'Brien, MD; Elizabeth Brem, MD

6

Wednesday, May 8, 2024

Safety, Data Storage & Reporting

Alexandre Chan, PharmD, MPH; Farshid Dayyani, MD

7

Wednesday, May 22, 2024

Data Analysis, Publication & Next Steps

Misako Nagasaka, MD, PhD; Christine Hui, MPH

8

Wednesday, June 5, 2024

Panel Q&A

All above faculty

For questions about the Cancer Clinical Trial Bootcamp, contact Kimberly Castellanos at kecastel@hs.uci.edu